Application Notes - International Biopharmaceutical Industry

Current Edition

Application Notes

The Benefits of 5,000L Single-use Bioreactors for Biologics Manufacturing

Executive Summary The entry of the 5,000L single-use bioreactor (SUB) into biologics manufacturing is providing an important bridge between small-scale and ...

19 December 2024 Application Notes | Volume 7 Issue 4

Continue Reading →

Volume 7 Issue 3

Next-generation Proximity-based Luminescence Assays & CRISPR/Cas9 Genome Engineering and nanoBRET

Bioluminescence resonance energy transfer (BRET) is a technology often used to probe the proximity of molecules within live cells. BRET assays have many applications...

30 September 2024 Volume 7 Issue 3 | Application Notes

Continue Reading →

Volume 7 Issue 3

Meeting Drug Development Challenges:An Insider’s View on CDMO Services for Biologics

As industry leaders and customers from across the globe gathered to discuss the latest trends and challenges in drug development and manufacturing at this year’s BIO...

30 September 2024 Volume 7 Issue 3 | Application Notes

Continue Reading →

Volume 7 Issue 3

Unlocking Early Drug Development Potential with CDMO Expertise

Early-phase drug product development and manufacturing are crucial steps in transforming promising drug candidates into viable, life-changing therapies. In the fast-...

30 September 2024 Volume 7 Issue 3 | Application Notes

Continue Reading →

Volume 7 Issue 3

NK Cell Therapy – An IP Update

Advances in CAR-T cell therapy have carved a path for improved treatments in the field of oncology, in particular haematological cancers. In 2018, the European Medic...

30 September 2024 Volume 7 Issue 3 | Application Notes

Continue Reading →

Volume 7 Issue 2

Safeguarding your IP: Thermo Fisher Scientific Pharma Services’ Global Commitment to Confidentiality

Intellectual property (IP) rights and confidentiality protections play a critical role in biopharmaceutical development and manufacturing. Appropriate protections en...

3 July 2024 Volume 7 Issue 2 | Application Notes | Editorial Archives

Continue Reading →

Volume 7 Issue 2

Understanding Roller Compaction in Pharmaceutical Development

David O'Connell of PCI Pharma Services explores the advancements in dry granulation and the fundamentals of roller compaction, presenting it as a viable alternative ...

3 July 2024 Volume 7 Issue 2 | Application Notes | Editorial Archives

Continue Reading →

Volume 7 Issue 2

Isosterix Uses CDD Vault to ExpediteDrug Discovery & Securely Collaborate

SituationRoopa Rai is the Founder and CEO of Isosterix. With over 25 years of experience, Roopa has held leadership positions in discovery research in various therap...

3 July 2024 Volume 7 Issue 2 | Application Notes | Editorial Archives

Continue Reading →

Volume 7 Issue 1

A Guide to Understanding and Performing all Appropriate Validation Steps When Adopting a New Endotoxin Testing Reagent

Limitations of Common Endotoxin Testing Solutions The adaptation of in-house endotoxin testing for a pharmaceutical or medical device manufacturer can be a daunting ...

16 April 2024 Volume 7 Issue 1 | Application Notes

Continue Reading →

Volume 7 Issue 1

Optimising Pharmaceutical Processes: A Guide to Lyophilisation Cycle Development

Lyophilisation, commonly known as freeze-drying, is a critical unit operation in the pharmaceutical industry used to preserve and stabilise both small and large-mole...

16 April 2024 Volume 7 Issue 1 | Application Notes

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.